Exact Mass: 460.1529

Exact Mass Matches: 460.1529

Found 20 metabolites which its exact mass value is equals to given mass value 460.1529, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Dexloxiglumide

4-{[(3,4-dichlorophenyl)(hydroxy)methylidene]amino}-4-[(3-methoxypropyl)(pentyl)carbamoyl]butanoic acid

C21H30Cl2N2O5 (460.1532)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.

   

CHEMBL188737

CHEMBL188737

C27H24O7 (460.1522)


   

BE-24566B

BE-24566B

C27H24O7 (460.1522)


An organic heterohexacyclic compound that is 6,7,9,16-tetrahydro-14H-6,16-epoxyanthra[2,3-e]benzo[b]oxocin-14-one substituted by hydroxy groups at positions 3, 11, 13 and 15, methyl groups at positions 1 and 4 and geminal methyl groups at position 9 respectively. It is isolated from the fermentation broth of Streptomyces violaceusniger and exhibits moderate antibacterial activity.

   

Bequinostatin B

Bequinostatin B

C27H24O7 (460.1522)


   

Phenazostatin A

Phenazostatin A

C28H20N4O3 (460.1535)


   
   

amarastelline A

amarastelline A

C28H20N4O3 (460.1535)


   

Dexloxiglumide

Dexloxiglumide

C21H30Cl2N2O5 (460.1532)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist[1]. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8)[2].

   

Loxiglumide

Loxiglumide

C21H30Cl2N2O5 (460.1532)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.

   

3,11,13,15-tetrahydroxy-1,6,9,9-tetramethyl-6,7,9,16-tetrahydro-14H-6,16-epoxyanthra[2,3-e]benzo[b]oxocin-14-one

3,11,13,15-tetrahydroxy-1,6,9,9-tetramethyl-6,7,9,16-tetrahydro-14H-6,16-epoxyanthra[2,3-e]benzo[b]oxocin-14-one

C27H24O7 (460.1522)


   

RGD (Trifluoroacetate)

RGD (Trifluoroacetate)

C14H23F3N6O8 (460.1529)


RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion, addresses certain cell lines and elicits specific cell responses; RGD Trifluoroacetate binds to integrins.

   

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

3-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

C27H24O7 (460.1522)


   

methyl 6-[(1r)-1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

methyl 6-[(1r)-1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

C28H20N4O3 (460.1535)


   

methyl 6-[1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

methyl 6-[1-(phenazin-2-yloxy)ethyl]phenazine-1-carboxylate

C28H20N4O3 (460.1535)


   

5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

C27H24O7 (460.1522)


   

(11r)-5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

(11r)-5,11,13,17,19-pentahydroxy-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4,6,8,13,16,18,20-nonaene-15,22-dione

C27H24O7 (460.1522)


   

(1r,17r)-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

(1r,17r)-3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

C27H24O7 (460.1522)


   

8-(4-hydroxy-3-methoxyphenyl)-6-[(4-hydroxy-3-methoxyphenyl)methyl]-2-methoxy-7-methylnaphthalene-1,4-dione

8-(4-hydroxy-3-methoxyphenyl)-6-[(4-hydroxy-3-methoxyphenyl)methyl]-2-methoxy-7-methylnaphthalene-1,4-dione

C27H24O7 (460.1522)


   

3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

3,7,9,21-tetrahydroxy-12,12,17,23-tetramethyl-18,25-dioxahexacyclo[15.7.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹.0¹⁹,²⁴]pentacosa-2,4(13),6,8,10,14,19(24),20,22-nonaen-5-one

C27H24O7 (460.1522)


   

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 1-hydroxy-4-methoxynaphthalene-2-carboxylate

C27H24O7 (460.1522)